e-learning
resources
Virtual 2021
05.09.2021
Vaccination and infections
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
New pertussis vaccine
A. Correia De Sousa (Porto, Portugal)
Source:
Virtual Congress 2021 – Vaccination and infections
Session:
Vaccination and infections
Session type:
Joint session
Number:
70
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. Correia De Sousa (Porto, Portugal). New pertussis vaccine. Virtual Congress 2021 – Vaccination and infections
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: Diagnostic tools for Obstructive Sleep Apnoea in adults and children
Expert interview: Physiological classification of lung function impairment
Occupational exposures to respiratory diseases: A case-based discussion
Related content which might interest you:
New Influenza vaccines
Source: Virtual Congress 2021 – Vaccination and infections
Year: 2021
Pertussis: waning immunity after vaccination in adults and recent increase of pertussis in infants
Source: Eur Respir J 2001; 18: Suppl. 33, 154s
Year: 2001
Use of the pneumococcal 23-valent polysaccharide vaccine in recruits in Russia
Source: Eur Respir J 2004; 24: Suppl. 48, 363s
Year: 2004
Cost-effectiveness of adult pneumococcal conjugate vaccination in the Netherlands
Source: Eur Respir J 2015; 46: 1407-1416
Year: 2015
Influenza and pneumococcal vaccination
Source: International Congress 2017 – State of the art session: "Respiratory infections"
Year: 2017
Pneumococcal and influenza vaccination
Source: Eur Respir Monogr 2014; 63: 266-284
Year: 2014
Additive preventive effect of influenza and pneumococcal vaccines in elderly persons
Source: Eur Respir J 2004; 23: 363-368
Year: 2004
Immunogenicity and safety of a novel recombinant pandemic influenza vaccine containing a polysaccharide adjuvant
Source: Annual Congress 2010 - Influenza A (H1N1) and other viral infections: therapeutic aspects
Year: 2010
Introduction of the 13-valent pneumococcal conjugate vaccine in an isolated pneumococcal vaccine-naïve indigenous population
Source: Eur Respir J 2016; 48: 1492-1496
Year: 2016
Pneumococcal vaccination: current and future issues
Source: Eur Respir J 2001; 18: 184-195
Year: 2001
Impact of introducing the 10-valent pneumococcal conjugate vaccine on childhood hospitalizations for bacterial pneumonia in Brazil
Source: Annual Congress 2013 –Paediatric respiratory epidemiology: bronchiolitis and asthma
Year: 2013
Safety and immunogenicity of hemophilus influenzae type B conjugate vaccine in COPD
Source: Annual Congress 2008 - Improving asthma and anti-allergic therapy
Year: 2008
Pneumococcal vaccination
Source: Eur Respir J 2005; 26: 982-983
Year: 2005
Previous pneumococcal polysaccharide vaccine impacts immune response to subsequent pneumococcal conjugate vaccine in the elderly
Source: Eur Respir J 2005; 26: Suppl. 49, 673s
Year: 2005
Effectiveness of a 23-valent pneumococcal polysaccharide vaccine and a 13-valent pneumococcal conjugate vaccine among the elderly with chronic respiratory diseases
Source: International Congress 2018 – Pneumonia: from the community to the intensive care unit
Year: 2018
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept